Holds one active US DMF and one valid CEP for letrozole, filing since 2011. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Holds one active US DMF and one valid CEP for letrozole, filing since 2011. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Holds 2 active US DMFs and one valid CEP for letrozole, filing since 2008. Its 2020 FDA inspection closed as NAI, and its GMP is recognised in 15 markets.
Holds one active US DMF and 4 valid CEPs for letrozole, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds 4 active US DMFs and one valid CEP for letrozole, filing since 2005. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 15 markets.
Holds one active US DMF for letrozole, filing since 2007. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and one valid CEP for letrozole, filing since 2013. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one valid CEP for letrozole, filing since 2024. Its GMP is recognised in 14 markets.
Holds 2 valid CEPs for letrozole, filing since 2024. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 8 markets.
Holds one active US DMF for letrozole, filing since 2024. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds one active US DMF for letrozole, filing since 2006. Its 2022 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one valid CEP for letrozole, filing since 2026. Its GMP is recognised in 15 markets.
Holds one active US DMF for letrozole, filing since 2024.
Registered with SFDA (Saudi Arabia) for letrozole. Its GMP is recognised in 3 markets.
Registered with SFDA (Saudi Arabia) for letrozole. Its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for letrozole and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2025 | $4985.00 | 25 |
| 2024 | $5000.00 | 20 |
| 2023 | $6669.91 | 19 |
| 2022 | $6702.61 | 13 |
US dollars per kilogram, customs export unit values.